Technical outlook – The rebound from $60.00 back in March 2020, has now fulfilled its bullish journey since closing the gap viewed back in February 2020 after hitting a peak at $87.00.
From a technical perspective, the Relative Strength Index (RSI) 3-period lookback is showing downward momentum, while the Moving Average Convergence Divergence (MACD) is bearish.
It is now assessed, this share is set on a downward journey to $70.00 and reassess from there.
Company Overview – Blackmores Limited (BKL) is a natural health company engaged in the development, sales and marketing of natural health products for humans and animals. It combines traditional naturopathic expertise with scientific research to produce products that include vitamins and herbal and mineral nutritional supplements.
Products are distributed through retail pharmacies, supermarkets, health food stores, mass merchants and distributors.
BKL operates in Australia, New Zealand and Asia. Former Names: Blackmores Laboratories Ltd, 07/12/1989.